Lido Advisors’s NanoViricides NNVC Stock Holding History

Lido Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,100	Closed	-$65K	–	322
2017 Q3	$65K	Buy	3,100 +600	+24%	+$16.1K	0.01%	278
2017 Q2	$68K	Hold	2,500	–	–	0.01%	269
2017 Q1	$58K	Hold	2,500	–	–	0.02%	235
2016 Q4	$54K	Hold	2,500	–	–	0.01%	218
2016 Q3	$85K	Hold	2,500	–	–	0.03%	148
2016 Q2	$80K	Hold	2,500	–	–	0.02%	154
2016 Q1	$110K	Buy	+2,500	New	+$97K	0.04%	138

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Lido Advisors's NNVC Position: Q4 2017 in Review

Lido Advisors sold out of NanoViricides (NNVC) in Q4 2017, closing a stake of 3,100 shares — an estimated $65K sold.

Lido Advisors first reported a position in NNVC in Q1 2016 and held it in 7 quarters. The position peaked at $110K in Q1 2016. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2017.

Lido Advisors reported no remaining NanoViricides position as of Q4 2017 after selling out during the quarter.
Lido Advisors sold 3,100 NanoViricides shares in Q4 2017, an estimated $65K.
Lido Advisors first reported a position in NanoViricides in Q1 2016 and held it in 7 quarters.
Lido Advisors's NanoViricides position peaked at $110K in Q1 2016.
44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2017.

Based on Lido Advisors's 13F filing for Q4 2017, filed 15 Feb 2018.